The FDA recently approved updated Covid vaccines but limited their use to older adults over 65 and high-risk groups, excluding healthy adults. This decision ended broad emergency authorizations, creating uncertainty about vaccine access and coverage for the general population. Critics, including vaccine skeptics and medical organizations, have voiced concerns about limited access for children and pregnant women. Major vaccine manufacturers share prices experienced slight changes amid this shift in policy.